Healthcare provider profile · identity verified

James C. Li, MD

Internal Medicine · PANORAMA CITY, CA · NPI 1275681140

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	631	229
Amlodipine Besylate	Amlodipine Besylate	412	145
Rosuvastatin Calcium	Rosuvastatin Calcium	334	125
Lisinopril	Lisinopril	311	111
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	306	72
Losartan Potassium	Losartan Potassium	306	113
Levothyroxine Sodium	Levothyroxine Sodium	232	79
Omeprazole	Omeprazole	219	87
Metformin Hcl Er	Metformin Hcl	218	79
Potassium Chloride	Potassium Chloride	195	76
Metformin Hcl	Metformin Hcl	190	65
Gabapentin	Gabapentin	177	65
Pantoprazole Sodium	Pantoprazole Sodium	159	60
Albuterol Sulfate Hfa	Albuterol Sulfate	152	76
Glipizide	Glipizide	149	56
Tamsulosin Hcl	Tamsulosin Hcl	125	46
Simvastatin	Simvastatin	120	40
Atenolol	Atenolol	114	42
Jardiance	Empagliflozin	107	43
Terazosin Hcl	Terazosin Hcl	92	32
Ozempic	Semaglutide	90	14
Meloxicam	Meloxicam	86	47
Bisoprolol Fumarate	Bisoprolol Fumarate	81	30
Pradaxa	Dabigatran Etexilate Mesylate	81	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	80	23
Hydrochlorothiazide	Hydrochlorothiazide	77	29
Trazodone Hcl	Trazodone Hcl	75	32
Tramadol Hcl	Tramadol Hcl	74	15
Fluticasone Propionate	Fluticasone Propionate	70	27
Metoprolol Tartrate	Metoprolol Tartrate	70	24
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	70	26
Triamcinolone Acetonide	Triamcinolone Acetonide	61	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	20
Humulin N Kwikpen	Insulin Nph Human Isophane	57	16
Montelukast Sodium	Montelukast Sodium	57	21
Clopidogrel	Clopidogrel Bisulfate	53	18
Wixela Inhub	Fluticasone Propion/Salmeterol	53	26
Alendronate Sodium	Alendronate Sodium	52	21
Famotidine	Famotidine	52	24
Pravastatin Sodium	Pravastatin Sodium	51	17
Furosemide	Furosemide	49	19
Lorazepam	Lorazepam	49	suppressed
Allopurinol	Allopurinol	47	17
Finasteride	Finasteride	47	16
Spiriva Respimat	Tiotropium Bromide	45	14
Breyna	Budesonide/Formoterol Fumarate	44	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	42	42
Spironolactone	Spironolactone	40	15
Lactulose	Lactulose	38	20
Humulin N	Insulin Nph Human Isophane	37	14
Sertraline Hcl	Sertraline Hcl	35	13
Ibuprofen	Ibuprofen	34	20
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	33
Duloxetine Hcl	Duloxetine Hcl	31	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Hydrocortisone	Hydrocortisone	31	17
Mirtazapine	Mirtazapine	31	13
Azelastine Hcl	Azelastine Hcl	30	15
Colchicine	Colchicine	29	suppressed
Azithromycin	Azithromycin	28	28
Fluoxetine Hcl	Fluoxetine Hcl	27	13
Levetiracetam	Levetiracetam	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	11
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	27	13
Acetaminophen-Codeine	Acetaminophen With Codeine	26	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Dulera	Mometasone/Formoterol	26	suppressed
Eliquis	Apixaban	25	suppressed
Metoprolol Succinate	Metoprolol Succinate	25	suppressed
Nystatin	Nystatin	25	suppressed
Victoza 2-Pak	Liraglutide	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Humulin R	Insulin Regular, Human	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Liraglutide	Liraglutide	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Mupirocin	Mupirocin	21	17
Alvesco	Ciclesonide	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Prednisone	Prednisone	20	16
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Amoxicillin	Amoxicillin	17	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	suppressed
Cefadroxil	Cefadroxil	17	17
Lovastatin	Lovastatin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	15	14
Santyl	Collagenase Clostridium Hist.	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Flunisolide	Flunisolide	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	11
Pregabalin	Pregabalin	13	suppressed
Temazepam	Temazepam	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	11
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error